# Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease

> **NCT06772220** · NA · RECRUITING · sponsor: **Oregon Health and Science University** · enrollment: 150 (estimated)

## Conditions studied

- Parkinson&Amp;#39;s Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Folic Acid 1 MG
- **DIETARY_SUPPLEMENT:** Vitamin B6 25 MG
- **DIETARY_SUPPLEMENT:** Vitamin B12

## Key facts

- **NCT ID:** NCT06772220
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-05
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06772220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06772220, "Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06772220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*